tiprankstipranks
Trending News
More News >
National Healthcare Corp. (NHC)
XASE:NHC
US Market

National Healthcare (NHC) Ratios

Compare
135 Followers

National Healthcare Ratios

NHC's free cash flow for Q4 2025 was $0.68. For the 2025 fiscal year, NHC's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.77 1.77 1.81 1.89 1.79
Quick Ratio
1.77 1.77 1.77 1.86 1.75
Cash Ratio
0.44 0.44 0.32 0.50 0.30
Solvency Ratio
0.36 0.36 0.27 0.27 0.16
Operating Cash Flow Ratio
0.73 0.73 0.46 0.52 0.04
Short-Term Operating Cash Flow Coverage
4.50 4.50 14.31 0.00 0.00
Net Current Asset Value
$ -3.72M$ -3.72M$ -116.86M$ 5.92M$ -44.00M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.06 0.14 0.07 0.10
Debt-to-Equity Ratio
0.08 0.08 0.22 0.10 0.14
Debt-to-Capital Ratio
0.08 0.08 0.18 0.09 0.13
Long-Term Debt-to-Capital Ratio
0.03 0.03 0.12 0.00 0.00
Financial Leverage Ratio
1.43 1.43 1.56 1.44 1.46
Debt Service Coverage Ratio
3.35 3.66 12.74 332.24 108.40
Interest Coverage Ratio
9.06 22.52 20.74 176.34 56.65
Debt to Market Cap
0.03 0.03 0.08 0.00 0.00
Interest Debt Per Share
6.50 6.04 14.22 6.12 8.21
Net Debt to EBITDA
-0.11 -0.11 0.76 -0.10 0.99
Profitability Margins
Gross Profit Margin
46.43%67.84%37.52%37.60%36.13%
EBIT Margin
11.74%11.18%10.83%7.80%2.59%
EBITDA Margin
14.70%14.15%14.06%11.48%6.36%
Operating Profit Margin
8.06%9.50%6.61%5.00%2.97%
Pretax Profit Margin
10.71%10.75%10.51%7.77%2.53%
Net Profit Margin
7.92%7.95%7.85%5.85%2.09%
Continuous Operations Profit Margin
8.09%8.12%7.87%5.72%1.86%
Net Income Per EBT
73.89%73.89%74.72%75.28%82.42%
EBT Per EBIT
132.90%113.23%159.06%155.32%85.37%
Return on Assets (ROA)
7.86%7.86%6.69%5.10%1.76%
Return on Equity (ROE)
11.57%11.23%10.40%7.35%2.57%
Return on Capital Employed (ROCE)
9.60%11.27%6.65%5.21%2.96%
Return on Invested Capital (ROIC)
7.02%8.24%4.83%3.73%2.10%
Return on Tangible Assets
8.98%8.98%7.64%5.88%2.04%
Earnings Yield
4.88%5.66%6.16%4.72%2.45%
Efficiency Ratios
Receivables Turnover
10.91 10.87 9.56 10.47 10.71
Payables Turnover
35.67 21.34 31.81 37.11 40.46
Inventory Turnover
0.00 0.00 89.71 96.45 96.81
Fixed Asset Turnover
0.00 0.00 1.70 1.94 1.71
Asset Turnover
0.99 0.99 0.85 0.87 0.84
Working Capital Turnover Ratio
7.47 7.86 6.81 6.56 6.73
Cash Conversion Cycle
23.23 16.48 30.79 28.82 28.82
Days of Sales Outstanding
33.47 33.59 38.20 34.87 34.07
Days of Inventory Outstanding
0.00 0.00 4.07 3.78 3.77
Days of Payables Outstanding
10.23 17.11 11.47 9.83 9.02
Operating Cycle
33.47 33.59 42.27 38.65 37.84
Cash Flow Ratios
Operating Cash Flow Per Share
11.96 11.96 6.97 7.26 0.57
Free Cash Flow Per Share
9.61 9.61 5.18 5.44 -1.39
CapEx Per Share
2.36 2.36 1.79 1.82 1.96
Free Cash Flow to Operating Cash Flow
0.80 0.80 0.74 0.75 -2.45
Dividend Paid and CapEx Coverage Ratio
2.46 2.46 1.66 1.75 0.13
Capital Expenditure Coverage Ratio
5.08 5.08 3.89 3.99 0.29
Operating Cash Flow Coverage Ratio
2.13 2.13 0.50 1.19 0.07
Operating Cash Flow to Sales Ratio
0.12 0.12 0.08 0.10 <0.01
Free Cash Flow Yield
6.02%7.01%4.81%5.89%-2.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.47 17.67 16.24 21.18 40.85
Price-to-Sales (P/S) Ratio
1.63 1.40 1.28 1.24 0.85
Price-to-Book (P/B) Ratio
2.30 1.98 1.69 1.56 1.05
Price-to-Free Cash Flow (P/FCF) Ratio
16.61 14.27 20.77 16.98 -42.73
Price-to-Operating Cash Flow Ratio
13.28 11.46 15.43 12.72 104.89
Price-to-Earnings Growth (PEG) Ratio
1.10 1.03 0.31 0.11 -0.49
Price-to-Fair Value
2.30 1.98 1.69 1.56 1.05
Enterprise Value Multiple
10.97 9.81 9.83 10.69 14.41
Enterprise Value
2.44B 2.10B 1.79B 1.40B 984.18M
EV to EBITDA
10.97 9.81 9.83 10.69 14.41
EV to Sales
1.61 1.39 1.38 1.23 0.92
EV to Free Cash Flow
16.44 14.11 22.51 16.82 -45.87
EV to Operating Cash Flow
13.21 11.33 16.72 12.60 112.58
Tangible Book Value Per Share
57.15 57.15 51.50 48.02 45.57
Shareholders’ Equity Per Share
69.08 69.08 63.67 59.36 56.73
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.25 0.26 0.27
Revenue Per Share
97.99 97.63 84.32 74.56 69.71
Net Income Per Share
7.76 7.76 6.62 4.36 1.46
Tax Burden
0.74 0.74 0.75 0.75 0.82
Interest Burden
0.91 0.96 0.97 1.00 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.01 0.00 0.03 0.04 0.04
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.51 1.51 1.05 1.70 0.44
Currency in USD